Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5626
PUT
National Beverage
FIZZ
$2.91B
| $1.01M | ﹤0.01% |
33,200
+17,400
| +110% | +$470K |
|
|
VIRX
5627
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.01M | ﹤0.01% |
109,933
+6,969
| +7% | +$105K |
|
|
PPLC
5628
DELISTED
PortfolioPlus S&P 500 ETF
PPLC
| $1.01M | ﹤0.01% |
24,554
-6,848
| -22% | -$264K |
|
5629
iShares Genomics Immunology and Healthcare ETF
IDNA
$218M
| $1.01M | ﹤0.01% |
+26,651
| New | +$900K |
|
5630
PUT
MSC Industrial Direct
MSM
$6.97B
| $1.01M | ﹤0.01% |
13,900
-800
| -5% | -$51.6K |
|
|
BBU
5631
DELISTED
Brookfield Business Partners
BBU
| $1.01M | ﹤0.01% |
51,123
+8,136
| +19% | +$157K |
|
|
PLAN
5632
DELISTED
Anaplan, Inc.
PLAN
| $1.01M | ﹤0.01% |
22,332
-1,486,557
| -99% | -$62.2M |
|
5633
Boot Barn
BOOT
$4.88B
| $1.01M | ﹤0.01% |
46,834
+35,276
| +305% | +$690K |
|
5634
ProShares Ultra Russell2000
UWM
$265M
| $1.01M | ﹤0.01% |
41,578
-161,162
| -79% | -$3.37M |
|
5635
PUT
Invesco S&P 500 Low Volatility ETF
SPLV
$7.14B
| $1.01M | ﹤0.01% |
20,300
-3,800
| -16% | -$187K |
|
5636
CALL
Opko Health
OPK
$1.01B
| $1.01M | ﹤0.01% |
295,600
+143,900
| +95% | +$322K |
|
5637
Puma Biotechnology
PBYI
$453M
| $1.01M | ﹤0.01% |
96,605
-147,463
| -60% | -$1.53M |
|
|
WMGI
5638
PUT
DELISTED
Wright Medical Group Inc
WMGI
| $1.01M | ﹤0.01% |
33,900
+13,200
| +64% | +$386K |
|
5639
CALL
Affiliated Managers Group
AMG
$9.83B
| $1.01M | ﹤0.01% |
13,500
-2,100
| -13% | -$142K |
|
5640
CALL
SouthState Bank Corp
SSB
$10.8B
| $1.01M | ﹤0.01% |
+21,100
| New | +$1.1M |
|
5641
Invesco Building & Construction ETF
PKB
$378M
| $1M | ﹤0.01% |
32,985
-59,500
| -64% | -$1.58M |
|
5642
Regional Management Corp
RM
$309M
| $1M | ﹤0.01% |
56,663
-20,231
| -26% | -$316K |
|
5643
Service Corp International
SCI
$11.4B
| $1M | ﹤0.01% |
25,815
-35,519
| -58% | -$1.36M |
|
5644
CALL
Magnachip Semiconductor
MX
$135M
| $1M | ﹤0.01% |
97,400
-4,900
| -5% | -$54.6K |
|
5645
CALL
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.8M
| $1M | ﹤0.01% |
7,450
-6,775
| -48% | -$907K |
|
|
TRUE
5646
DELISTED
TrueCar
TRUE
| $1M | ﹤0.01% |
388,491
+39,515
| +11% | +$101K |
|
5647
Vishay Precision Group
VPG
$998M
| $1M | ﹤0.01% |
40,756
+12,136
| +42% | +$273K |
|
|
UCB
5648
United Community Banks
UCB
$4.43B
| $1M | ﹤0.01% |
49,772
-22,160
| -31% | -$424K |
|
5649
PUT
AES
AES
$10.5B
| $1M | ﹤0.01% |
69,000
+18,600
| +37% | +$244K |
|
5650
Arcutis Biotherapeutics
ARQT
$3.25B
| $1M | ﹤0.01% |
33,089
-22,476
| -40% | -$650K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.